|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
A multicenter phase II study to evaluate safety and efficacy of glutadon once weekly (GDO) in patients with metastatic colorectal cancer resistant or intolerable to approved chemo- and molecular-targeted therapies
100 项与 New Medical Enzymes Ag 相关的临床结果
0 项与 New Medical Enzymes Ag 相关的专利(医药)
100 项与 New Medical Enzymes Ag 相关的药物交易
100 项与 New Medical Enzymes Ag 相关的转化医学